ankeetbhatt Profile Banner
Ankeet S. Bhatt, MD, MBA Profile
Ankeet S. Bhatt, MD, MBA

@ankeetbhatt

Followers
3K
Following
20K
Media
144
Statuses
2K

Crit. Care Cardiology @kpdor | Adjunct Prof. @StanfordMed | Prior @MassGenBrigham @IMresidencyDuke | Interests: Trials + ImpSci | AE @JCardFail | Tweet≠endorse

San Francisco, CA
Joined June 2018
Don't wanna be here? Send us removal request.
@TorBiering
Tor Biering-Sørensen, MD, MSc, MPH, PhD
1 day
Please find the Quick Take Video of our DANFLU-2 trial in the current issue of @NEJM below 👇 Congratulations @niklasdj1 and the whole @CTCPR_ team on this important GIGA trial 👏
@NEJM
NEJM
1 day
Whether the high-dose influenza vaccine is more effective than the standard-dose vaccine in preventing severe outcomes of influenza in older adults is unclear. Research findings from the DANFLU-2 trial are summarized in a new Quick Take video. https://t.co/M1XTtMbynl
0
3
10
@TorBiering
Tor Biering-Sørensen, MD, MSc, MPH, PhD
2 days
Amazing trial by @ankeetbhatt and the whole @KPDOR team! We are very excited to collaborate with the brilliant scientist @ankeetbhatt on pragmatic RCT’s. Much more to come!
@CTCPR_
CTCPR Trials & CIRL
2 days
🫀 KP-VACCINATE Megatrial in @AmHeartJ! @CTCPR_ collaborated on the KP-VACCINATE trial led by @ankeetbhatt and colleagues from Kaiser Permanente. 3.6M+ adults randomized to test whether cardiovascular (CV) focused messaging boosts influenza vaccination vs usual care. Key
0
2
9
@CTCPR_
CTCPR Trials & CIRL
2 days
🫀 KP-VACCINATE Megatrial in @AmHeartJ! @CTCPR_ collaborated on the KP-VACCINATE trial led by @ankeetbhatt and colleagues from Kaiser Permanente. 3.6M+ adults randomized to test whether cardiovascular (CV) focused messaging boosts influenza vaccination vs usual care. Key
0
4
9
@CassSunstein
Cass Sunstein
9 days
Just out! Nudges in A Learning Health System: Applications to Cardiovascular-Kidney-Metabolic Care @PennNudgeUnit @kevin_volpp https://t.co/cdV0uzvU4g
Tweet card summary image
research.regionh.dk
0
2
10
@KPDOR
Kaiser Permanente Research NorCal
8 days
How might nudges improve care? @ankeetbhatt and colleagues provide great overview in this paper now in @JACCJournals
@ankeetbhatt
Ankeet S. Bhatt, MD, MBA
8 days
SOTA Review: Nudges in a Learning Health System: Applications to #CKM Care now out in @JACCJournals. Wonderful to work with @Deoliveiragdc @CassSunstein @mvaduganathan @TorBiering & others on a forward-looking vision of coordinated nudges to improve health https://t.co/r6hgKlrORV
0
3
3
@ankeetbhatt
Ankeet S. Bhatt, MD, MBA
8 days
SOTA Review: Nudges in a Learning Health System: Applications to #CKM Care now out in @JACCJournals. Wonderful to work with @Deoliveiragdc @CassSunstein @mvaduganathan @TorBiering & others on a forward-looking vision of coordinated nudges to improve health https://t.co/r6hgKlrORV
3
13
29
@Deoliveiragdc
Diana De Oliveira Gomes, MD
9 days
Excited to share our paper: “Nudges in a Learning Health System: Applications to Cardiovascular–Kidney–Metabolic Care.” @JACCJournals A deep dive into how behavioral science can enhance CKM care @CassSunstein @ankeetbhatt, @mvaduganathan @hfcollaboratory https://t.co/x5ZZttNYof
1
5
19
@Deoliveiragdc
Diana De Oliveira Gomes, MD
9 days
From EHR defaults to AI-driven personalization, we outline how nudges can improve guideline use, preventive care, and patient engagement at scale.
0
4
8
@gcfmd
Gregg Fonarow MD
10 days
Primary HF 🏨 in the US 2010 to 2022 Where is all the progress in preventing and treating HF??? Failure in discoveries? Failure in translation? Failure in implementation? https://t.co/IdAmM0d94y @JavedButler1 @HeartDocSadiya @DLBHATTMD @NMHheartdoc @robmentz @rblument1
1
12
20
@gcfmd
Gregg Fonarow MD
11 days
HF hospitalizations among adults aged <65 years continued to rise, highlighting a shift in epidemiological landscape in which HF increasingly affects younger populations @HeartDocSadiya @AndrewJSauer @NMHheartdoc @DLBHATTMD @ankeetbhatt @robmentz @MKIttlesonMD @AHAScience
0
2
7
@JAMACardio
JAMA Cardiology
12 days
Editorial: The DANFLU-2 trial demonstrated that high-dose influenza vaccines have minor clinical advantages over standard-dose ones, highlighting the need for a health system focused on evidence rather than financial incentives. https://t.co/fdenJseLi6
1
13
31
@NEJM
NEJM
14 days
Nishant Uppal, MD, MBA (@NishantUppal7), discusses the emergence of venture capital investing by academic medical centers and its potential implications. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/InKcsIY42R
1
10
31
@drbennisahmed
Ahmed Bennis MD 🫀
14 days
Assessing Medical Therapy Optimization in Cardiovascular-Kidney-Metabolic Clinical Trials: An Initiative From the Heart Failure Collaboratory CKM conditions now have over- lapping disease-modifying, evidence-based treatments, and the therapeutic landscape is expanding with new
0
21
71
@ankeetbhatt
Ankeet S. Bhatt, MD, MBA
22 days
Fantastic to join #Renal colleagues at the @goKDIGO Controversies Conference on how digital tools can support #ImplementationSci. Frustrating to see the same issues (low testing, inertia, ⏬ adherence) plaguing both fields. Time for holistic #CKM #ImpSci + precision approaches?
1
6
22
@drbennisahmed
Ahmed Bennis MD 🫀
23 days
2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure: A Report of the American College of Cardiology Given emerging evidence of the benefits of semaglutide and tirzepatide in individuals with HFpEF and obesity in concert with healthy behavioral
3
25
78
@dranulala
Anu Lala (Anuradha Lala-Trindade)
24 days
Where do 🩺👩🏽‍⚕️👨‍⚕️have a home to discuss & share info? 🤔 This very question led me to join Roon as a Founding Physician. Clinical conversations are scattered across platforms that weren’t built for medical communities and most AI tools stop at the published literature, missing
2
7
35
@ankeetbhatt
Ankeet S. Bhatt, MD, MBA
26 days
jacc.org
0
1
4
@ankeetbhatt
Ankeet S. Bhatt, MD, MBA
26 days
Lots of #CKM discussions @AHAScience. With⏫CKM comorbidity & overlapping treatments, tools should move beyond condition-specific tx optimization. In @JACCJournals from @hfcollaboratory, #ScoreCKM provides a unified medication optimization score across CKM for trials & pt care
3
27
68
@ankeetbhatt
Ankeet S. Bhatt, MD, MBA
28 days
What factors are associated with #IMPROVED ejection fraction after incident #HFrEF in the context of modern GDMT? In @JCardFail #simpub with @AHAScience, we highlight the strong association of early (within 90d) #GDMT optimization and incident #HFimpEF. https://t.co/mT7sQGEjf0
1
22
57